Clinical Trial Update: 3 Month Outcome of Ziv-aflibercept for DME [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports 3-month outcomes for Ziv-aflibercept in diabetic macular edema in Phase 2 and Phase 3, with the study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ziv-aflibercept (ziv-aflibercept)

Snippet

Sponsor: Marashi Eye Clinic | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: COMPLETED